Citeline recently introduced a new Therapeutic Class called "Adoptive cell therapy", enabling more granular searching capabilities to hone in on this exciting cancer immunotherapy that is expanding the horizon of personalized medicine
Watch Ms. Branon’s lively presentation and discover how central access to one comprehensive source for relevant, timely clinical trial data and trial benchmarks vastly improves your study planning and feasibility processes.
Becoming the “expert to the experts” for your pharma and CRO clients
Using data from the newly redesigned Citeline suite of intelligence tools, Ms. Branon, a member of the Citeline team for over 10 years and Director of Sitetrove, will use her expertise to elucidate the connection between leveraging top-quality intelligence and becoming the “expert to the experts” for your pharma and CRO clients. With her years of experience in the field, especially in site feasibility, staff management, and helping clients develop strategies to identify the most experienced investigators and trial sites, Ms. Branon’s insights are sure to enlighten.
Get a deeper understanding of breast cancer clinical trials initiated since 2014 and what the trends have meant for strategies in this area, with this free whitepaper from Citeline.
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: